Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to ...

BeOne Medicines is up 75% in 2025 but off recent highs. China’s new private insurance drug list could unlock major growth for ONC in 2026.

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

Biotech Showcase™ returns to San Francisco during J.P. Morgan Healthcare Week, marking its 19 th year as a premier ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Nanobiotix (NBTX +3.54%) is a French biotechnology stock, and one that has soared 660% in 2025 as of Nov. 18. That's enough to draw investor attention, and to have many wondering ...

This milestone comes at a time when India's homoeopathic sector is undergoing rapid transformation under the leadership of PM Narendra Modi, said the company.